Latest Business Development News

PainChek has completed its final FDA submission for the PainChek Adult App, targeting the US long-term care market with a potential $100 million annual opportunity. A regulatory decision is expected within 75 days, setting the stage for rapid commercialisation.

Copper Search Limited made significant strides in the June 2025 quarter, revealing promising Heavy Mineral Sands potential in South Australia and securing a strategic option over a major NSW gold-copper project, while raising $1.15 million to fuel its exploration ambitions.

Openn Negotiation Ltd remains under a Deed of Company Arrangement with no operational activity during the September quarter, focusing on recapitalisation efforts following insolvency and voluntary administration.

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

Locate Technologies has successfully raised nearly $400,000 through its ATM facility, bolstering its cash reserves to support growth in its delivery optimisation platforms.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.

Locate Technologies has made a strategic move by investing A$1 million in Bitcoin, aiming to leverage cryptocurrency as a growth catalyst while continuing to advance its core delivery platforms.